These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12958450)

  • 21. Cell specificity and efficiency of the Semliki forest virus vector- and adenovirus vector-mediated gene expression in mouse cerebellum.
    Sato Y; Shiraishi Y; Furuichi T
    J Neurosci Methods; 2004 Aug; 137(1):111-21. PubMed ID: 15196833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live viral vectors: vaccinia virus.
    Staib C; Sutter G
    Methods Mol Med; 2003; 87():51-68. PubMed ID: 12958449
    [No Abstract]   [Full Text] [Related]  

  • 23. Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells.
    Wahlfors JJ; Xanthopoulos KG; Morgan RA
    Hum Gene Ther; 1997 Nov; 8(17):2031-41. PubMed ID: 9414252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional activity of a biotinylated human neurokinin 1 receptor fusion expressed in the Semliki Forest virus system.
    Lundstrom K; Vargas A; Allet B
    Biochem Biophys Res Commun; 1995 Mar; 208(1):260-6. PubMed ID: 7887938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional expression and direct visualization of the human alpha 2B -adrenergic receptor and alpha 2B -AR-green fluorescent fusion protein in mammalian cell using Semliki Forest virus vectors.
    Sen S; Jaakola VP; Heimo H; Engström M; Larjomaa P; Scheinin M; Lundstrom K; Goldman A
    Protein Expr Purif; 2003 Dec; 32(2):265-75. PubMed ID: 14965773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semliki Forest virus vectors for large-scale production of recombinant proteins.
    Lundstrom K
    Methods Mol Med; 2003; 76():525-43. PubMed ID: 12526183
    [No Abstract]   [Full Text] [Related]  

  • 27. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.
    Kim TW; Hung CF; Juang J; He L; Hardwick JM; Wu TC
    Gene Ther; 2004 Feb; 11(3):336-42. PubMed ID: 14737094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector.
    Benmaamar R; Astray RM; Wagner R; Pereira CA
    J Biotechnol; 2009 Feb; 139(4):283-90. PubMed ID: 19135103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.
    Witko SE; Kotash CS; Nowak RM; Johnson JE; Boutilier LA; Melville KJ; Heron SG; Clarke DK; Abramovitz AS; Hendry RM; Sidhu MS; Udem SA; Parks CL
    J Virol Methods; 2006 Jul; 135(1):91-101. PubMed ID: 16569439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies in subviral components of Semliki Forest virus.
    Kääriäinen L; Simons K; von Bonsdorff CH
    Ann Med Exp Biol Fenn; 1969; 47(4):235-48. PubMed ID: 5393678
    [No Abstract]   [Full Text] [Related]  

  • 32. Semliki Forest virus vectors for overexpression of 101 G protein-coupled receptors in mammalian host cells.
    Hassaine G; Wagner R; Kempf J; Cherouati N; Hassaine N; Prual C; André N; Reinhart C; Pattus F; Lundstrom K
    Protein Expr Purif; 2006 Feb; 45(2):343-51. PubMed ID: 16055346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid, high level protein production using DNA-based Semliki Forest virus vectors.
    DiCiommo DP; Bremner R
    J Biol Chem; 1998 Jul; 273(29):18060-6. PubMed ID: 9660762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-replicating Semliki Forest virus RNA as recombinant vaccine.
    Zhou X; Berglund P; Rhodes G; Parker SE; Jondal M; Liljeström P
    Vaccine; 1994 Dec; 12(16):1510-4. PubMed ID: 7879415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules.
    Zeng J; Fournier P; Schirrmacher V
    Int J Oncol; 2004 Aug; 25(2):293-302. PubMed ID: 15254725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and concentration of alphavirus.
    Lundstrom K
    Cold Spring Harb Protoc; 2012 Jul; 2012(7):832-4. PubMed ID: 22753601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of angiostatin using DNA-based semliki forest virus replicon.
    Choi YS; Lee JS; Choi YK; Shin KS; Kim HS; Kim CJ
    J Vet Sci; 2002 Mar; 3(1):41-5. PubMed ID: 14614271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The translation-enhancing region of the Semliki Forest virus subgenome is only functional in the virus-infected cell.
    Sjöberg EM; Garoff H
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1323-7. PubMed ID: 8683222
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of insect cell gene expression in pharmaceutical research.
    Thomsen DR; Meyer AL; Post LE
    Bioprocess Technol; 1993; 17():105-38. PubMed ID: 7764046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.